As of close of business last night, Avenue Therapeutics Inc’s stock clocked out at $0.15, down -4.30% from its previous closing price of $0.15. In other words, the price has decreased by -$0.0066 from its previous closing price. On the day, 746697 shares were traded.
Ratios:
To gain a deeper understanding of ATXI’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.55 and its Current Ratio is at 1.55. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 11 ’23 when Davidow Robert L sold 353,000 shares for $0.14 per share. The transaction valued at 49,600 led to the insider holds 22,000 shares of the business.
Davidow Robert L sold 264,000 shares of ATXI for $36,960 on Dec 11 ’23. The 10% Owner now owns 681,000 shares after completing the transaction at $0.14 per share. On Sep 08 ’23, another insider, Fortress Biotech, Inc., who serves as the 10% Owner of the company, bought 418,410 shares for $0.72 each. As a result, the insider paid 301,255 and bolstered with 1,032,390 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATXI now has a Market Capitalization of 6.56M and an Enterprise Value of 4.78M.
Stock Price History:
Over the past 52 weeks, ATXI has reached a high of $1.30, while it has fallen to a 52-week low of $0.11. The 50-Day Moving Average of the stock is 0.1522, while the 200-Day Moving Average is calculated to be 0.4828.
Shares Statistics:
It appears that ATXI traded 1.87M shares on average per day over the past three months and 743.35k shares per day over the past ten days. A total of 44.26M shares are outstanding, with a floating share count of 38.53M. Insiders hold about 12.96% of the company’s shares, while institutions hold 2.79% stake in the company. Shares short for ATXI as of Mar 15, 2024 were 313.39k with a Short Ratio of 0.17, compared to 337.74k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.71% and a Short% of Float of 0.71%.
Earnings Estimates
As of right now, 1 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.12 for the current quarter, with a high estimate of -$0.12 and a low estimate of -$0.12, while EPS last year was -$1.35. The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.1 and low estimates of -$0.1.
Analysts are recommending an EPS of between -$0.41 and -$0.41 for the fiscal current year, implying an average EPS of -$0.41. EPS for the following year is -$0.37, with 1 analysts recommending between -$0.37 and -$0.37.
